Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy
Update on a completed clinical trial assessing the effect of mannitol on optic nerve sheath diameter in patients undergoing robotic prostate…
-
CLINICAL_TRIALS research · 2017-08-25Clinical Trial Update: Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer
This clinical trial update reports on a study evaluating hypofractionated intensity-modulated radiotherapy with image-guided radiotherapy fo…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer [Phase 1]
Phase 1 trial evaluating the combination of Sipuleucel-T and Ipilimumab for advanced or castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA) [Phase 2]
Phase 2 trial evaluating GM-CSF for patients with rising PSA in prostate cancer; the study is completed.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Prehabilitation for Prostate Cancer Surgery [Phase 1, Phase 2]
This clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating prehabilitation for patients with prostate cancer un…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies [NA]
The STHLM3-MR trial comparing standard versus targeted prostate biopsies for prostate cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2017-08-22Clinical Trial Update: Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management [Phase 2]
A Phase 2 clinical trial evaluating 68Ga-PSMA PET-CT for detection of prostate cancer recurrence and its impact on patient management has be…
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Navigator Guided e-Psychoeducational Intervention
This document reports a completed clinical trial evaluating a navigator-guided e-psychoeducational intervention for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Prostate Delineation: High Quality Volume CT [NA]
This is an update on a completed clinical trial evaluating high-quality volume CT for prostate delineation in prostate cancer. The sponsor i…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy [Phase 3]
Phase 3 trial evaluating radiation therapy with or without bicalutamide for recurrent pT3N0 prostate cancer after radical prostatectomy; res…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating a peptide-specific vaccination in HLA-A*02 positive patients with biochemical recurrence afte…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial evaluating chemotherapy response monitoring with 18F-choline PET/CT in hormone-refractory…
-
CLINICAL_TRIALS research · 2017-08-11Clinical Trial Update: Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial [Phase 2]
Phase II clinical trial evaluating focal brachytherapy for selected low-risk prostate cancer patients, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: A Study of Imatinib and Docetaxel in Prostate Cancer [Phase 2]
Phase 2 study evaluating the combination of imatinib and docetaxel for prostate cancer; results have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study [NA]
The document reports the completion of a proof-of-concept clinical trial evaluating prostatic artery embolization before radical prostatecto…
-
FDA approval · 2017-08-09FDA Approved: DOCETAXEL — Original Application (Jiangsu Hengrui Pharmaceuticals Co., Ltd.)
FDA approved a generic version of docetaxel under an original ANDA from Jiangsu Hengrui Pharmaceuticals Co., Ltd., enabling market authoriza…
-
CLINICAL_TRIALS research · 2017-08-08Clinical Trial Update: Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583
This clinical trial update notes that plasma and urine samples were collected from patients with hormone-refractory prostate cancer enrolled…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy
This clinical trial update reports on vascular changes in patients undergoing laparoscopic radical prostatectomy. The study status is comple…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer [Phase 1]
A completed Phase 1 study evaluated safety, tolerability, pharmacokinetics, and dynamic effects of different doses of EMD 525797 in prostate…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy
A clinical trial is evaluating the Non-invasive 4D Ultrasound Clarity System for use in prostate IMRT/RapidArc therapy. The current status o…
-
CLINICAL_TRIALS research · 2017-08-01Clinical Trial Update: Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) [NA]
A completed clinical trial update describing the characterization of circulating tumor cells captured via c-MET (CTC-MET) across multiple ca…
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: PROFIT - Prostate Fractionated Irradiation Trial [Phase 3]
Phase 3 clinical trial PROFIT evaluating Prostate Fractionated Irradiation for prostate cancer has completed. The update notes the study sta…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer [Phase 2]
Phase 2 trial evaluating Samarium-153 Lexidronam Pentasodium with 3D-conformal radiotherapy or intensity-modulated radiotherapy in patients …
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Patient Preference Survey for Radiation Oncologists [NA]
A completed clinical trial update from the University of Pittsburgh describes a patient preference survey related to radiation oncology, cov…
-
FDA approval · 2017-07-24FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) submitted by Astellas Pharma US, Inc.